Skip to content

Clinical trial of individual cognitive Behavioral Therapy for chronic pain (single arm trial)

Clinical trial of individual cognitive Behavioral Therapy for chronic pain (single arm trial) - Clinical trial of Cognitive Behavioral Therapy for chronic pain

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000027153
Enrollment
15
Registered
2017-04-26
Start date
2017-05-09
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Somatic symptom disorder with mainly pain

Interventions

Cognitive Behavioral Therapy(16 weeks)

Sponsors

Chiba University Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients falling under all the following conditions are targeted. 1) Those who satisfy the diagnostic criteria for somatic symptoms (primary pain) in DSM5 (not excluding depression or other anxiety disorder). 2) Persons who are 18 years of age or older at the time of consent acquisition. 3) After being fully informed of participation of this exam, after fully understanding, it is based on the individual's willingness to do so. Person who obtained document consent form (in case of minors, including parental consent) 4) It can understand cognitive behavioral therapy and has mental and physical condition that can be practiced on a sustainable basis for at least 1 year.

Exclusion criteria

Exclusion criteria: Those who fall under any of the following conditions are not included. 1) Persons who are expected to have cessation of behavioral cognitive therapy due to complications of severe mental disorders such as organic brain disorder, psychotic disorder, bipolar disorder, drug dependence etc due to these symptoms worsening 2) Persons who have mental developmental delay (refer to JART - 25: Japanese Adult Reading Test25) 3) Those with neurocognitive disorders (dementia) (MMSE: refer to evaluation scores by Mini Mental State examination) 4) those with autistic spectrum spectroscopy (AQ: refer to Autism Spectrum Index) 5) Persons who are expected to have cessation of cognitive behavioral therapy because of the danger of impending suicide. 6) Persons who are anticipated to have cessation of cognitive behavioral therapy because they repeat anti-social behavior. 7) Persons who are predictive of cessation of cognitive behavioral therapy because they have significant progressive physical disorder. 8) Persons who are difficult to contact with researchers. 9) Other persons who are judged inappropriate for the examination responsible doctor or the test sharing psychologist to safely carry out this test.

Design outcomes

Primary

MeasureTime frame
1.Numerical Rating Scale (NRS) 2.Pain Catastrophizing Scale (PCS) (Both are evaluated after 16 weeks.)

Secondary

MeasureTime frame
After 8 weeks, 1.Numerical Rating Scale (NRS) 2.Pain Catastrophizing Scale (PCS) After 16 weeks, 3.Pain Disability Assessment Scale (PDAS) 4.PHQ-9(Patient Health Questionnare-9) 5.GHQ-7(Generalized anxiety disorder-7) 6.EQ-5D-5L(EuroQol5-Dimension-5Levels)

Countries

Japan

Contacts

Public ContactKayoko Taguchi

Chiba University Cognitive Behavior Physiology Laboratory

k.taguchi@chiba-u.jp043-226-2027

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026